Fundraising Overview - The company raised a total of RMB 34 million by issuing 34 million shares at RMB 9.79 per share, with net proceeds amounting to RMB 27,704.58 million after deducting issuance costs of RMB 2,381.42 million [1][2] - The funds were deposited into a dedicated account managed under a tripartite supervision agreement with banks and the sponsor [2][3] Fund Utilization and Balance - As of June 30, 2025, the company had invested RMB 8,132.63 million from the net proceeds, with a net interest income of RMB 3,115.87 million, resulting in a remaining balance of RMB 22,687.82 million [2][3] - The company has not encountered any abnormal situations regarding the investment projects funded by the raised capital [5][6] Fund Management Practices - The company has established a management system for the raised funds in compliance with relevant laws and regulations, ensuring dedicated storage and efficient use of the funds [2][3] - The company has opened three dedicated bank accounts for the raised funds, with balances reported as follows: RMB 4,567,688.79 at Shaoxing Bank, RMB 1,474,888.17 at Ningbo Bank, and RMB 42,835,597.97 at Agricultural Bank of China [3] Project Adjustments and Strategic Decisions - The company decided to use RMB 35.7 million from the unutilized funds for acquiring a 51% stake in Shanghai Shixin Software Co., aiming to enhance its business structure and competitive advantage in the gas control industry [6][7] - The timelines for certain projects, such as the R&D center upgrade and information system upgrade, have been extended to May 2027 due to market conditions and strategic considerations [6][7][9] Financial Management and Cash Management - The company has approved the use of up to RMB 200 million of idle funds for cash management, including investments in structured deposits [7][8] - As of June 30, 2025, RMB 178 million was invested in structured deposits, with the remaining funds reserved for future project payments [7][8]

关于新增募集资金专户并签订三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意新疆众和股份有限公司向不特定对象发行可转换公司债 券注册的批复》（证监许可〔2023〕1445号），同意新疆众和股份有限公司（以下简称"公司"）向不特 定对象发行面值总额1,375,000,000.00元可转换公司债券，期限6年，每张面值为人民币100元，发行数量 13,750,000张，募集资金总额为人民币1,375,000,000.00元，扣除发行费用等相关费用后，募集资金净额 为人民币1,359,255,896.23元。上述募集资金已全部到位，并经希格玛会计师事务所（特殊普通合伙）审 验，于2023年7月25日出具了《新疆众和股份有限公司验资报告》（希会验字(2023)0028号）。 证券代码：600888 证券简称：新疆众和 编号：临2025-061号 债券代码：110094 债券简称：众和转债 新疆众和股份有限公司 二、变更募集资金用途情况 公司于2025年5月 ...

Group 1 - The board of directors of Jiahe Intelligent Technology Co., Ltd. held its 27th meeting on August 12, 2025, with all 9 directors present, meeting the legal requirements for quorum [1] - The board approved the proposal to submit the acquisition agreement with conditions to the shareholders' meeting, with a unanimous vote of 9 in favor [2] - The board also approved the proposal to change the use of raised funds, which will be submitted to the shareholders' meeting and bondholders' meeting for further approval, also with a unanimous vote of 9 in favor [2][3] Group 2 - The board approved the revision of certain clauses in the company's articles of association, with a unanimous vote of 9 in favor, pending submission to the shareholders' meeting [3] - The board reviewed and approved several amendments to company regulations, all receiving unanimous support of 9 votes in favor, pending submission to the shareholders' meeting [3] - The board approved the proposal to hold the first temporary shareholders' meeting of 2025, with a unanimous vote of 9 in favor [3][4] Group 3 - The board approved the proposal to hold the first bondholders' meeting for Jiahe Convertible Bonds in 2025, with a unanimous vote of 9 in favor [4] - The decisions made during the meeting are documented in the resolutions of the third strategic committee meeting and the 27th board meeting [4][5]

Meeting Details - The meeting was held on August 8, 2025, at 14:30, with network voting available from 9:15 to 15:00 on the same day [1] - A total of 32.3534% of the voting shares were represented at the meeting, with 4 shareholders present in person representing 61,563,856 shares (13.6596% of total voting shares) and 106 shareholders voting online representing 84,252,608 shares (18.6938% of total voting shares) [1] Voting Results - The proposal to change the use of raised funds and permanently supplement remaining funds into working capital was approved, with 145,547,264 shares in favor, accounting for the majority of the voting shares present [2] - Among minority shareholders, 2,303,738 shares voted in favor (89.5373%), while 256,200 shares opposed (9.9575%), and 13,000 shares were abstained [3] Legal Opinion - The legal representatives confirmed that the meeting's procedures complied with relevant laws and regulations, and the qualifications of attendees and the convenor were valid [3]

本次会议审议通过了以下议案： 证券代码：002791 证券简称：坚朗五金 公告编号：2025-034 广东坚朗五金制品股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 广东坚朗五金制品股份有限公司（以下简称"公司"）第四届监 事会第二十三次会议于2025年6月16日在广东省东莞市塘厦镇坚朗路 子邮件等方式向全体监事发出，应出席会议监事3人，实际出席会议 监事3人，公司董事会秘书殷建忠先生列席了本次会议。会议由监事 会主席马龙先生主持。本次会议的召集、召开符合《中华人民共和国 公司法》《公司章程》的有关规定。 二、监事会会议审议情况 （一）关于变更部分募集资金用途及实施进度的议案 监事会认为：公司本次变更部分募集资金用途及实施进度是充分 考虑当前市场环境及公司发展战略所作出的审慎决定，有利于提高募 集资金使用效率。该事项符合相关法律法规的规定，决策程序合法有 效，不存在违规使用募集资金的情形，也不存在损害公司和全体股东 利益的情况。因此，监事会一致同意本次变更部分募集资金用途及实 施进度的事项。 详见公司同日登载于巨潮资讯网（ ...

Group 1 - The company held its fourth meeting of the fifth supervisory board on May 29, 2025, with all three supervisors present, and the meeting complied with relevant regulations [1][2] - The supervisory board approved the adjustment of certain fundraising projects and the change of part of the fundraising purposes, stating that these changes align with the company's strategic development needs and improve the efficiency of fundraising use [1][2] - The voting results showed unanimous support for the proposal, with 3 votes in favor, 0 against, and 0 abstentions, and the proposal will be submitted to the company's third extraordinary general meeting of shareholders in 2025 for further review [2]

证券代码：300497 证券简称：富祥药业 公告编号：2025-011 江西富祥药业股份有限公司 1、审议通过《关于变更募集资金用途并将剩余募集资金永久补充流动资金的议 案》 经审核，监事会认为：公司本次变更募集资金用途并将剩余募集资金永久补充流 动资金事项，是基于公司实际情况做出的合理决策，符合公司实际经营需要，有利于 提高公司募集资金的使用效率，有利于维护全体股东的利益，符合公司发展战略，符 合《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《深圳 证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关规定， 不存在损害公司及股东利益特别是中小股东利益的情形。 表决结果：3票同意，0票反对，0票弃权。 本议案尚需提交公司股东大会审议。 特此公告。 第四届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、监事会会议召开情况 江西富祥药业股份有限公司（以下简称"公司"）第四届监事会第十六次会议通 知于 2025 年 2 月 19 日以电子邮件等方式通知全体监事，并于 2025 年 2 月 ...